<DOC>
	<DOCNO>NCT02480686</DOCNO>
	<brief_summary>This study evaluate efficacy safety NEUTRINO regimen Chinese chronic HCV genotype 1b treatment-experienced patient .</brief_summary>
	<brief_title>Neutrino Regimen Treatment-experienced HCV GT1 Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>1 . Age equal great 18 year , chronic genotype 1b infection ; 2 . HCV RNA equal great 10,000 IU/mL Screening ; 3 . Cirrhosis determination ; 4 . Subjects treatmentexperienced ; 5 . Screening laboratory value within defined threshold ; 6 . Use highly effective contraception method female childbearing potential sexually active male . 1 . HIV chronic hepatitis B virus ( HBV ) infection ; 2 . Contraindications PEG RBV therapy ; 3 . Hematologic biochemical parameter Screening outside protocolspecified requirement ; 4 . Active recent history ( â‰¤ 1 year ) drug alcohol abuse ; 5 . Hepatocellular carcinoma malignancy ( exception certain resolve skin cancer ) ; 6 . Chronic use systemic immunosuppressive agent ; 7 . History current evidence condition , therapy , laboratory abnormality circumstance might confound result study , interfere subject 's participation full duration study , best interest subject participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>